Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0002041,serum uric acid level,,,,67.2,umol/l,2.5311,6.2,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70284,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood uric acid amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0002041,serum uric acid level,,,,107.3,umol/l,3.1843,7.8,MMO:0000329,liquid phase colorimetry,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70285,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours)